Publication | Closed Access
Evaluation of the first Ergocalciferol-derived, non hypercalcemic anti-cancer agent MT19c in ovarian cancer SKOV-3 cell lines
16
Citations
24
References
2011
Year
OncologyMedicineAnti-cancer AgentCancer TreatmentPharmacologyRadiation OncologyTumor MicroenvironmentEndocrine-related CancerOvarian CancerFirst Ergocalciferol-derived
| Year | Citations | |
|---|---|---|
Page 1
Page 1